Intravenous thrombolysis for acute ischaemic stroke

Effective blood pressure control matters

Georgios Tsivgoulis, Vasilios Kotsis, Sotirios Giannopoulos

Research output: Contribution to journalComment/debate

16 Citations (Scopus)

Abstract

In this Leading opinion we summarise the observational evidence endorsing current guidelines that advocate effective blood pressure control before and during an rtPA infusion and indicate that a more active blood pressure-lowering approach immediately after intravenous thrombolysis appears to be a promising therapeutic option that should be formerly evaluated in a randomised clinical trial setting. Acute ischaemic stroke is a highly treatable neuroemergency and the efficacy of the available treatment is not only related to the speed by which it is administered but also by the effective control of modifiable adverse outcome predictors including elevated blood pressure levels.

Original languageEnglish (US)
Pages (from-to)125-127
Number of pages3
JournalInternational Journal of Stroke
Volume6
Issue number2
DOIs
StatePublished - Apr 1 2011
Externally publishedYes

Fingerprint

Stroke
Blood Pressure
Randomized Controlled Trials
Guidelines
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neurology

Cite this

Intravenous thrombolysis for acute ischaemic stroke : Effective blood pressure control matters. / Tsivgoulis, Georgios; Kotsis, Vasilios; Giannopoulos, Sotirios.

In: International Journal of Stroke, Vol. 6, No. 2, 01.04.2011, p. 125-127.

Research output: Contribution to journalComment/debate

@article{c515ec0996b2494bbf331568cb5e4675,
title = "Intravenous thrombolysis for acute ischaemic stroke: Effective blood pressure control matters",
abstract = "In this Leading opinion we summarise the observational evidence endorsing current guidelines that advocate effective blood pressure control before and during an rtPA infusion and indicate that a more active blood pressure-lowering approach immediately after intravenous thrombolysis appears to be a promising therapeutic option that should be formerly evaluated in a randomised clinical trial setting. Acute ischaemic stroke is a highly treatable neuroemergency and the efficacy of the available treatment is not only related to the speed by which it is administered but also by the effective control of modifiable adverse outcome predictors including elevated blood pressure levels.",
author = "Georgios Tsivgoulis and Vasilios Kotsis and Sotirios Giannopoulos",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1747-4949.2010.00570.x",
language = "English (US)",
volume = "6",
pages = "125--127",
journal = "International Journal of Stroke",
issn = "1747-4930",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Intravenous thrombolysis for acute ischaemic stroke

T2 - Effective blood pressure control matters

AU - Tsivgoulis, Georgios

AU - Kotsis, Vasilios

AU - Giannopoulos, Sotirios

PY - 2011/4/1

Y1 - 2011/4/1

N2 - In this Leading opinion we summarise the observational evidence endorsing current guidelines that advocate effective blood pressure control before and during an rtPA infusion and indicate that a more active blood pressure-lowering approach immediately after intravenous thrombolysis appears to be a promising therapeutic option that should be formerly evaluated in a randomised clinical trial setting. Acute ischaemic stroke is a highly treatable neuroemergency and the efficacy of the available treatment is not only related to the speed by which it is administered but also by the effective control of modifiable adverse outcome predictors including elevated blood pressure levels.

AB - In this Leading opinion we summarise the observational evidence endorsing current guidelines that advocate effective blood pressure control before and during an rtPA infusion and indicate that a more active blood pressure-lowering approach immediately after intravenous thrombolysis appears to be a promising therapeutic option that should be formerly evaluated in a randomised clinical trial setting. Acute ischaemic stroke is a highly treatable neuroemergency and the efficacy of the available treatment is not only related to the speed by which it is administered but also by the effective control of modifiable adverse outcome predictors including elevated blood pressure levels.

UR - http://www.scopus.com/inward/record.url?scp=79952303726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952303726&partnerID=8YFLogxK

U2 - 10.1111/j.1747-4949.2010.00570.x

DO - 10.1111/j.1747-4949.2010.00570.x

M3 - Comment/debate

VL - 6

SP - 125

EP - 127

JO - International Journal of Stroke

JF - International Journal of Stroke

SN - 1747-4930

IS - 2

ER -